HIV inhibiting bicyclic pyrimidine derivatives

HIV replication inhibitors of formula wherein -a1=a2-a3=a4- is -CH CH-CH CH-, -N CH-CH CH-, -N CH-N CH-, -N CH-CH N-, -N N-CH CH-; -b1=b2-b3=b4- is -CH CH-CH CH-, -N CH-CH CH-, -N CH-N CH-, -N CH-CH N-, -N N-CH CH-; n and m is 0-4, R1 is hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyl; C1-6alky...

Full description

Saved in:
Bibliographic Details
Main Authors Guillemont, Jerôme Emile Georges, Delest, Bruno Francois Marie, Janssen, Paul Adriaan Jan, Heeres, Jan, Lewi, Paulus Joannes, Paugam, Mikaël
Format Patent
LanguageEnglish
Published 11.09.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract HIV replication inhibitors of formula wherein -a1=a2-a3=a4- is -CH CH-CH CH-, -N CH-CH CH-, -N CH-N CH-, -N CH-CH N-, -N N-CH CH-; -b1=b2-b3=b4- is -CH CH-CH CH-, -N CH-CH CH-, -N CH-N CH-, -N CH-CH N-, -N N-CH CH-; n and m is 0-4, R1 is hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyl; C1-6alkyloxycarbonyl; R2 is OH; halo; C1-6alkyl, C2-6alkenyl or C2-6alkynyl; substituted carbonyl; carboxyl; CN; nitro; amino; polyhalomethyl; polyhalomethylthio; -S( O)pR6; C( NH)R6; R2a is CN; amino; substituted amino; C1-6alkyl; halo; C1-6alkyloxy; carbonyl; -CH N-NH-C( O)-R16; C1-6alkyloxyC1-6alkyl; C2-6alkenyl or C2-6alkynyl; -C( N-O-R8)-C1-4alkyl; R7 or -X-R7; R3 is CN; amino; C1-6alkyl; halo; C1-6alkyloxy; substituted carbonyl; -CH N-NH-C( O)-R16; substituted C1-6alkyl; C1-6alkyloxyC1-6alkyl; substituted C2-6alkenyl or C2-6alkynyl; -C( N-O-R8)-C1-4alkyl; R7; -X-R7; R4 is halo; OH; C1-6alkyl, C2-6alkenyl or C2-6alkynyl; C3-7cycloalkyl; C1-6alkyloxy; CN; nitro; polyhaloC1-6alkyl; polyhaloC1-6alkyloxy; substituted carbonyl; formyl; amino; mono- or di(C1-4alkyl)amino or R7; -A-B- is -CR5 N-, -N N-, -CH2-CH2-, -CS-NH-, -CO-NH-, -CH CH-; and the use of these compounds for the prevention or the treatment of HIV infection.
AbstractList HIV replication inhibitors of formula wherein -a1=a2-a3=a4- is -CH CH-CH CH-, -N CH-CH CH-, -N CH-N CH-, -N CH-CH N-, -N N-CH CH-; -b1=b2-b3=b4- is -CH CH-CH CH-, -N CH-CH CH-, -N CH-N CH-, -N CH-CH N-, -N N-CH CH-; n and m is 0-4, R1 is hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyl; C1-6alkyloxycarbonyl; R2 is OH; halo; C1-6alkyl, C2-6alkenyl or C2-6alkynyl; substituted carbonyl; carboxyl; CN; nitro; amino; polyhalomethyl; polyhalomethylthio; -S( O)pR6; C( NH)R6; R2a is CN; amino; substituted amino; C1-6alkyl; halo; C1-6alkyloxy; carbonyl; -CH N-NH-C( O)-R16; C1-6alkyloxyC1-6alkyl; C2-6alkenyl or C2-6alkynyl; -C( N-O-R8)-C1-4alkyl; R7 or -X-R7; R3 is CN; amino; C1-6alkyl; halo; C1-6alkyloxy; substituted carbonyl; -CH N-NH-C( O)-R16; substituted C1-6alkyl; C1-6alkyloxyC1-6alkyl; substituted C2-6alkenyl or C2-6alkynyl; -C( N-O-R8)-C1-4alkyl; R7; -X-R7; R4 is halo; OH; C1-6alkyl, C2-6alkenyl or C2-6alkynyl; C3-7cycloalkyl; C1-6alkyloxy; CN; nitro; polyhaloC1-6alkyl; polyhaloC1-6alkyloxy; substituted carbonyl; formyl; amino; mono- or di(C1-4alkyl)amino or R7; -A-B- is -CR5 N-, -N N-, -CH2-CH2-, -CS-NH-, -CO-NH-, -CH CH-; and the use of these compounds for the prevention or the treatment of HIV infection.
Author Guillemont, Jerôme Emile Georges
Lewi, Paulus Joannes
Delest, Bruno Francois Marie
Heeres, Jan
Janssen, Paul Adriaan Jan
Paugam, Mikaël
Author_xml – fullname: Guillemont, Jerôme Emile Georges
– fullname: Delest, Bruno Francois Marie
– fullname: Janssen, Paul Adriaan Jan
– fullname: Heeres, Jan
– fullname: Lewi, Paulus Joannes
– fullname: Paugam, Mikaël
BookMark eNrjYmDJy89L5WTQ8_AMU8jMy8hMyizJzEtXSMpMrkzOyUxWKKgsyszNTMnMS1VISS3KLEssySxLLeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGhwYYGBuZGBoamTkbGxKgBAPydLJU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US10072015B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US10072015B23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:55:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10072015B23
Notes Application Number: US201715713404
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180911&DB=EPODOC&CC=US&NR=10072015B2
ParticipantIDs epo_espacenet_US10072015B2
PublicationCentury 2000
PublicationDate 20180911
PublicationDateYYYYMMDD 2018-09-11
PublicationDate_xml – month: 09
  year: 2018
  text: 20180911
  day: 11
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies Janssen Sciences Ireland UC
RelatedCompanies_xml – name: Janssen Sciences Ireland UC
Score 3.1709301
Snippet HIV replication inhibitors of formula wherein -a1=a2-a3=a4- is -CH CH-CH CH-, -N CH-CH CH-, -N CH-N CH-, -N CH-CH N-, -N N-CH CH-; -b1=b2-b3=b4- is -CH CH-CH...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title HIV inhibiting bicyclic pyrimidine derivatives
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180911&DB=EPODOC&locale=&CC=US&NR=10072015B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp6LzgwrSW7U1aVkPRegXVdgHbh27jSXpWD3UYquy_96X0DkvegsJJC-PvK_kvV8AbjOMqkwuqOE4C8egwiUG48QxBKH0gfWEZbmyGrk_cJKUPs_sWQteN7UwCif0S4EjokRxlPda6etye4kVqtzK6p7l2PX2GE-8UG-iYwlGhbIb-l40GobDQA8CLx3rgxdPJgPguO2jut6RbrTE2Y-mvqxKKX-blPgQdkc4W1EfQSsrOrAfbH5e68Bev3nwxmYje9Ux3CVPUy0vVjnLZaqyxnK-5kitVq7l11xogzJN4Hn6VFDe1QncxNEkSAxceP6zy3k63tJITqGN0X92BppNuVhyl6EfwCgxey76CNxcSKAqtkT7ew7dv-fp_jd4AQeSYzL5wbIuoV2_f2RXaGFrdq1Y8w0a2X8b
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT4MwEL4s0zjfdGp0_sLE8IaCFBwPxAQYYTrY4mDZG1kLi_iARFCz_94rYc4XfWva5Npe-vV67d1XgOsUvSqZJUTS9YUukcRQJcpUXUpUQu5oP1EUg2cj-4HuReRxrs1b8LrOhal5Qr9qckREFEO8V_V-XWwusZw6trK8pRlWvT24oemIjXfMyagQu45lDiZjZ2yLtm1GUzF4NnkwALZrFm7XW_foEnKe_cHM4lkpxW-T4u7B9gSl5dU-tNK8Cx17_fNaF3b85sEbiw32ygO48YYzIctfMprxUGWBZmzFcLRCseJfc6ENSoUE19NnTeVdHsKVOwhtT8KO459ZxtF0M0b1CNro_afHIGiEJUtmUDwHUKLKfQPPCExecKIqukT7ewK9v-X0_mu8hI4X-qN4NAyeTmGXa48HQijKGbSr94_0HK1tRS9qNX0DMjmCBg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HIV+inhibiting+bicyclic+pyrimidine+derivatives&rft.inventor=Guillemont%2C+Jer%C3%B4me+Emile+Georges&rft.inventor=Delest%2C+Bruno+Francois+Marie&rft.inventor=Janssen%2C+Paul+Adriaan+Jan&rft.inventor=Heeres%2C+Jan&rft.inventor=Lewi%2C+Paulus+Joannes&rft.inventor=Paugam%2C+Mika%C3%ABl&rft.date=2018-09-11&rft.externalDBID=B2&rft.externalDocID=US10072015B2